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ARTICULO ORIGINAL

DECREASE OF CARDIOVASCULAR RISK IN OBESE PATIENTS
WHO PARTICIPATED IN A LIFESTYLE MEDICINE PROGRAM
DISMINUCIÓN DEL RIESGO CARDIOVASCULAR EN PACIENTES OBESOS QUE PARTICIPARON
EN UN PROGRAMA DE MEDICINA DE ESTILO DE VIDA
Eymard Torres-Rodriguez 1,a , Lucy Cedillo-Ramirez 2,b

ABSTRACT
Lifestyle Medicine in the management of chronic diseases such as obesity is essential to reduce
cardiovascular risk and to reverse the disease process(1). Objective: To determine if a Lifestyle Medicine
program can reduce cardiovascular risk in obese adults in Colombia. Methods: Descriptive observational
study cases series type followed for 6 months in a Lifestyle Medicine Clinic. 9 patients were included taking
into account 2 measures of cardiovascular risk as a parameter to complete the program. The following
measurements were taken: cardiovascular risk using the Pan American Health Organization (PAHO)
calculator, Body Mass Index (BMI), lipid pro le, history of smoking, history of diabetes, and systolic blood
pressure. Results: Of the 9 obese patients, 22% had an intermediate cardiovascular risk and 78% had a low risk
at the beginning of the study. After 6 months, it was achieved that 100% of the participants had a low
cardiovascular risk; Furthermore, 11% of the patients managed to normalize their blood pressure values and
20% showed a decrease in high blood pressure values. In addition, 22% went from type 3 obesity to type 2
obesity. Finally, through psychological consultation, it was possible to reduce anxiety levels from high to
intermediate in at least 44% of the participants. Conclusions: The Lifestyle Medicine program, in a group of
obese patients, managed to achieve a low cardiovascular risk, the decrease and normalization of blood
pressure gures and reduction in BMI in participants who completed the study.
Keywords: Obesity, cardiovascular diseases, lifestyle, comorbidity, essential hypertension, diabetes mellitus
(Source: MeSH NLM)

RESUMEN
Introducción: La Medicina de estilo de vida en el manejo de enfermedades crónicas como la obesidad, es fundamental
para disminuir el riesgo cardiovascular y revertir el proceso de enfermedad (1) . Objetivo: Determinar si un programa de
Medicina de Estilo de Vida logra disminuir el riesgo cardiovascular en adultos obesos de Colombia. Metodología: Estudio
observacional descriptivo tipo serie de casos seguidos por 6 meses en una Clínica de Medicina de Estilo de Vida. Se
incluyeron 9 pacientes teniendo en cuenta 2 medidas del riesgo cardiovascular como parámetro para completar el
programa. Se tomaron los siguientes mediciones: riesgo cardiovascular, mediante la calculadora de la organización
panamericana de la Salud (OPS), Índice de Masa Corporal (IMC), per l lipídico, antecedentes de tabaquismo,
antecedentes de diabetes y presión arterial sistólica. Resultados: De los 9 pacientes obesos, el 22% tuvo un riesgo
cardiovascular intermedio y 78% presentaron riesgo bajo al inicio del estudio. Luego de 6 meses, se logró que el 100% de
los participantes tuvieran un riesgo cardiovascular bajo; además, el 11% de los pacientes lograron normalizar los valores
de presión arterial y un 20% evidenciaron disminución de valores elevados de presión arterial. Además, el 22%, pasaron
de obesidad tipo 3 a obesidad tipo 2. Por último, mediante la consulta psicológica se logró disminuir los niveles de
ansiedad de alto a intermedio en el 44% de los participantes. Conclusiones: El programa de Medicina de Estilo de vida, en
un grupo de obesos, logró disminuir el riesgo cardiovascular, logrando la disminución y normalización de las cifras
tensionales y la reducción del IMC .
Palabras clave: Obesidad, enfermedades cardiovasculares, estilo de vida, comorbilidad, hipertensión esencial, diabetes
mellitus (Fuente: DeCS BIREME)
Internal Medicine Specialist in Nutrition, Diabetes, Metabolism and Lifestyle Medicine
Medical surgeon.
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INTRODUCTION
In the last publication of the American College of
Cardiology, where they studied the worldwide rates of
cardiovascular disease from 1990 to 2019, they
concluded that prevalent cases of cardiovascular
diseases (CVD) almost doubled from 271 million
(interval of uncertainty [IU] of 95%: 257 to 285 million) in
1990 to 523 million (IU of 95%: 497 to 550 million) in
2019, and number of deaths from CVD increased
constantly from 12,1 million (95% IU: 11,4 to 12,6
million) in 1990, reaching 18,6 million (95% IU: 17,1 to
19,7 million) in 2019, concluded that the
cardiometabolic, behavioral, environmental and social
risk factors are the main promoters of cardiovascular
diseases. Among the main risk factors and behaviors for
developing cardiovascular disease in the general adult
population, we found arterial hypertension and obesity
at 45.9% and 39.6%, respectively (2) .
In Colombia, the Non-Transmissible Chronic Diseases
(NTCD) also represent the main cause of death. These
diseases represent a true epidemic that increases due to
population aging and current lifestyles that emphasize
sedentarism and poor diet (3) .
Obesity is strongly associated with a greater risk of
cardiovascular mortality, all-cause mortality and
mortality due to cancer ( 4 ) . On the other hand,
decreasing at least 1 kg of weight reduces the
possibility of developing type 2 diabetes by 16% (5) , and
if the weight loss is greater or equal to 5% from the initial
weight, we could reach a moderate improvement in
arterial pressure, low density lipoprotein cholesterol
(LDL-C), triglycerides, and glucose levels in overweight
or obese people, hence reducing their cardiovascular
risk (6) .
A great amount of scienti c and medical literature
exists that supports the concept that habits, and daily
actions have an enormous impact on health and short
and long-term quality of life (7) .This impact can be
positive or negative. Diverse studies oﬀer evidence that
regular physical activity, maintaining a healthy body
weight, not smoking cigarettes, and following solid
nutrition habits and health promotion deeply in uence
health. These aspects are part of the fundamental pillars
of which Lifestyle Medicine is based. This approach was
created from the need of studying how daily habits and
practices impact disease prevention as well as
treatment, often together with pharmaceutical or
surgical treatment, to oﬀer an important complement
to health in general (8) .
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Adherence to a healthy lifestyle during one’s entire life i
sable to signi cantly reduce cardiovascular risk up to
70%, and, therefore, it is a key component in the primary
prevention of cardiovascular diseases (9) . With an
adequate nutritional plan, guided by an
interdisciplinary team, we may be able to reach a
decrease of 8 to 14mmHg, knowing that each decrease
of 10mmHg in systolic arterial pressure, signi cantly
lowers the risk of any cardiovascular disease occurrence
(10)
.
There have been intensive programs carried out in Latin
America that cover Lifestyle programs (11) , however, we
have not had the experience of a similar program
applied to patients with obesity in Colombia.
Lifestyle Medicine in Colombia is currently represented
by the Asociación Colombiana de Medicina de Estilo de
Vida (AMESVIDA) and in Latin America by the Latin
American Lifestyle Medicine Association (LALMA). The
implementation of lifestyle medicine programs has
been developing in Colombia through some health
institutions whose objective was to implement
strategies and programs to revert diabetes in the
Colombian health system, as a rst experience (11) .
However, eﬀorts for promotion of Lifestyle Medicine
intervention programs in the medical practice are
needed for the purpose of preventing and treating
diﬀerent chronic and metabolic diseases. This is why,
this research seeks to determine if a decrease in
cardiovascular risk exists in an obese population that
participates in a Lifestyle Medicine program in
Colombia.

METHODS
Study design
Observational, descriptive, case series type study. The
data was obtained from the medical history of patients
seen in outpatient medical consult and who were
included in the Lifestyle Medicine program, this data
was consigned in a data collection sheet where age,
body mass index (BMI), blood pressure values,
complete lipid pro le values were included, from which
the 10-year cardiovascular risk was obtained. The
before-mentioned data were measured at the
beginning of the program ( rst month) and at the end
(sixth month).

Population and sample
The population was made up of obese male patients
who were seen at a Clínica Lifestile Medicina SAS to
participate in a Lifestyle Medicine program between
July and December 2019. A total of 13 patients with
obesity participated, however, 9 patients were
considered for the study, since they were the only ones
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who completed the intervention program. Since this
study is a follow up of a case series presented in a private
institution, it was not necessary to calculate sample size.

Inclusion and exclusion criteria
The study’s inclusion criteria were patients who
attended at least two consultations during the program
that lasted 6 months, and whose BMI was greater or
equal to 30, history of arterial hypertension, diabetes
mellitus and high lipid levels. We excluded the
participants who did not complete the program or who
only had one measure during the time of the study.

Variables
Through national and international literature review,
the following variables were included:
sociodemographic factors (age), obesity measured
through Body Mass Index according to staging
proposed by the World Health Organization – WHO,
blood pressure (categorized using the American Heart
Association classi cation – AHA), total cholesterol, LDL
cholesterol, bioimpedance measurement (corporal
composition study with the inbody 120 equipment)
and cardiovascular risk determination, which was
obtained from the Pan American Health Organization
calculator (PAHO), which include the following
dimensions: sex, age, smoking, diabetes, maximum
systolic blood pressure (SBPmax), maximum diastolic
blood pressure (DBPmax). All the variables mentioned
were measured at the beginning and end of the study.
This calculator was used since it was standardized for
the Colombian population and for the easy access for
health professionals in the measure of variables that
take part in determining cardiovascular risk.

Procedure
A data collection sheet was used as an instrument. With
the data collected during hte rst as well as the last
consultation, an Excel spreadsheet data base was
created. This base was processed in the statistical
program SPSS V.25 for its analysis. The information was
obtained through review of medical history. The
Lifestyle Medicine program was guided by an internal
medicine physician specialized in nutrition and
Lifestyle Medicine, who worked together with a team of
medical specialists.
The Lifestyle Medicine program that was developed
consisted of a personalized medical attention through
the application of the 6 pillars of Lifestyle Medicine: 1)
plant based nutrition free of ultra-processed foods: the
activity was under the care of a nutrition specialist, who
in addition to giving advice to participants, oﬀered a list
of ultra-processed products that the patients should
avoid consuming, additionally, in the assessment by the
nutrition/dietitian specialist the patients were told the
healthy plate method referred to plant based nutrition;

2). daily physical activity: in the consultation we
prescribed physical activity of 30 minutes daily
including, rapid walks, associated to resistance
exercises; 3). adequate daily rest: 8 hours of night sleep
was prescribed, we also gave sleep hygiene
recommendations such as how to avoid watching
television in the bedroom, how to avoid stimulating
drinks 2 hours before bedtime, avoiding the use of
electronic devices during bedtime and keeping at least
3-4 hours of fasting prior to going to sleep; 4). stress
control: a specialist taught the participants to practice a
few techniques on how to face stress, based on
behavioral cognitive therapy in a personalized and
group format, furthermore, participants’ stress levels
were measured through a perceived stress software
specialized in stress and anxiety classi cation (PSS) (12);
5). avoid harmful substances such as alcohol and
tobacco use, among others; 6) having a solid family and
professional companionship system through the
program: promoting family awareness, through group
sessions about the importance of practicing Lifestyle
Medicine with the aim of making them an eﬀective
support for the patients in the process of healthy
ac tivit y selec tions. Fur ther more, in the rst
consultation, the bioimpedance measurement,
anthropometry (BMI), blood pressure control, and
laboratory studies, which measure the initial levels of
total cholesterol and LDL cholesterol, were taken.
Each time the participants went for their assessment by
the health professional, a record of their prescribed
activities was carried out with the purpose of
controlling the activity compliance. The patient followup was done in person during consultations and
evaluations indicated during the program, but we also
followed-up by telephone during the 6 month duration
of the program. Finally, in addition to basal
measurement of the aspects mentioned in the
beginning of the follow-up ( rst month), another one
was carried out at the end of the program to compare
and describe results evidenced in the patients.

Statistical analysis
The SPSS V.25 statistical software was used for the
statistical analysis. The data was evaluated through
descriptive statistics, using frequencies percentages,
central tendency and dispersion method measures. The
results were presented comparatively in tables and bar
graphs.

Ethical considerations
For the study development, we considered the
anonymity of personal data, for the data base used as
well as for the information collection. Likewise, in order
to include patients in the Lifestyle Medicine program
we asked for the informed consent. Furthermore, the
study was approved by the Medical Ethical Committee
of the institution.
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RESULTS
The following are the results obtained in the
evaluations by the medical team trained in lifestyle
medicine. An initial report and a nal report was
presented at the end of the program. All the
participants were obese male Colombians, with an
average age of 51 years, average weight of 109 kg
approximately. 33% of obese patients had dyslipidemia
ad did not receive treatment, furthermore, 33% of
patients had hypertension and were under treatment
with antihypertensive medication. None of the
participants smoked tobacco and only one of them had
diabetes as personal history at the moment of initial
evaluation and he was under pharmacological
treatment.
We evidenced an intermediate Cardiovascular Risk
(CVR) in 22.2 % of participants at the beginning of the
study, after 6 months in the lifestyle medicine program,
100% of the study subjects were able to have a low CVR
of developing cardiovascular disease in 10 years.
Regarding obesity, 22% of total patients had obesity
type 3 at the beginning of the study, after a 6 month
follow up and at the end of the study none of the
subjects had this type of obesity. As far as blood
pressure measurements, 100% of participants had
some level of arterial hypertension (elevated, stage 1,
stage 2, or stage 3) at the beginning of the Lifestyle
Medicine program. According to the last blood pressure
control of the study subjects, 11,1% of participants were
able to normalize the blood pressure values. At the
beginning of the program, we were able to identify

cases of dyslipidemia. 55.6% of participants presented
hypercholesterolemia. The results from the second
control evidenced that the percentage of
hypercholesterolemia in participants decreased to
22.2%. Furthermore, 33.3% of patients studied had high
LDL in the beginning of the program, with a decrease in
LDL cholesterol levels to 22.2% at the end of the study.
Table 1 details the data regarding the variables
mentioned, with measures at the beginning and end of
the study. Furthermore, in table 2 the statistical data is
indicated (mean, standard deviation, and con dence
Interval) of the numerical variables measured at the
beginning and at the end of case follow-up.
Among the ndings of the perceived stress analysis
through a systemized survey, we were able to evidence
that all he patients went from high to moderate levels of
stress in the course of 6 months of the program
according to the sample in gure 2, furthermore, we
obtained a percentage of absence of up to 54% in
psychology consultations as is detailed in table 3.
The fat, muscle, and visceral fat percentage
determination was carried out through bioimpedance
measurement with our equipment Inbody 120. In table
4 the rst and last measurement performed on these
parameters in 9 study participants is described.
Fur thermore, according to the general body
composition analysis (table 5), we observed the
following results of the total number of patients during
the study: decrease of body fat percentage of 4.2%,
decrease of 6.5 kg of muscular mass and a decrease of
up to 5% of average visceral fat.

Table 1.

Variables measured at the beginning and end of the Lifestyle Medicine
program in obese adult patients in a private institution of Colombia, 2019
Variables

Initial Control
n (%)

Last Control
n (%)

Cardiovascular Risk
Low

7 (77.8%)

9 (100%)

Intermediate

2 (22.2%)

0 (0%)

0%

0%

4 (44.5%)

4 (44.4%)

High
Obesity
Type 1
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Type 2

3 (33.3%)

5 (55.6%)

Type 3

2 (22,2%)

0%

Normal

0%

1 (11.1%)

Elevated

3 (33.4%)

4 (44.5%)

Stage 1

2 (22.2%)

2 (22.2%)

Stage 2

3 (33.3%)

2 (22.2%)

Stage 3

1 (11.1%)

0%

Normal Cholesterol

4 (44.4%)

7 (77.8%)

High Cholesterol

5 (55.6%)

2 (22.2%)

Optimal LDL

6 (66.6%)

7 (77.8%)

Normal LDL

3 (33.3%)

2 (22.2%)

Blood Pressure

Total Cholesterol

LDL cholesterol

Source: Own preparation.

Table 2. Numerical variables measured at the beginning and end of the Lifestyle Medicine program in
obese adult patients in a private institution of Colombia, 2019

Variables

Minimum Maximum Mean

DS*

Conﬁdence Interval

BMI 1 (kg/mts2)

32

43

35,89

3,86

33.71

39.43

BMI 2 (kg/mts2)

32

39

35,11

2,42

33.71

37.14

Total Cholesterol 1 (mg/dl)

192

248

211,67

20,61

195.43

220.43

Total Cholesterol 2 (mg/dl)

190

217

199,29

9,19

193.72

206.00

LDL Cholesterol 1 (mg/dl)

51

160

121,78

32,36

91.73

135.86

LDL Cholesterol 2 (mg/dl)

65

150

117,44

23,56

113.86

134.00

Weight 1 (Kg)

89

141

109,67

16,99

100.57

125.57

Weight 2 (Kg)

87

127

106,89

12,99

99.43

118.28

Systolic Pressure 1 (mmHg)

120

150

132,22

10,92

122.86

138.57

Diastolic Pressure 1 (mmHg)

70

100

82,22

9,72

74.29

88.57

Systolic Pressure 2 (mmHg)

110

140

124,44

8,82

121.43

128.57

Diastolic Pressure 2 (mmHg)

70

90

78,89

6,009

75.71

84.29

Source: Own preparation. *Standard deviation

Dentro de los hallazgos del análisis de estrés percibido a
través de una encuesta sistematizada, logramos
evidenciar que todos los pacientes pasaron de alto
estrés a estrés moderado a lo largo de los 6 meses del

programa según se muestra en la gura 2; además, se
obtuvo un porcentaje de inasistencia de hasta un 54%
en las consultas por psicología como se detalla en la
tabla 3.
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Table 3. Frequency of attendance in the psychological consultations according to stress
level in obese patients that participated in the Lifestyle Medicine program

Month 1

Stress

Month 2

Month 3

Month 4

Month 5

Month 6

High level
Moderate level
Low level
Did not attend
Source: Own preparation.

month 1

month 2
High Stress

month 3

month 4

Moderate Stress

month 5

month 6

low stress

Figure 1. Stress levels in obese adults evaluated during the Lifestyle Medicine program

La determinación del porcentaje de grasa, músculo y
grasa visceral se hizo por medio de
bioimpedanciometría con nuestro equipo Inbody 120.
En la tabla 4 se detalla la primera y la última medida que
se realizó de estos parámetros en los 9 participantes del
estudio. Además, según el análisis de composición
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corporal general (tabla 5), notamos los siguientes
resultados del total de los pacientes durante el estudio:
disminución del porcentaje de grasa corporal en un
4.2%, disminución de 6.5 kilos de masa muscular y una
disminución de hasta un 5% de grasa visceral en
promedio.
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Table 4. Bioimpedance measurements of the fat, muscle, and visceral fat percentages of
obese patient during the 6 month follow up.
PARTICIPANT

MEASURE

WEIGHT

%FAT

%MUSCLE (KG)

VISCERAL FAT

Fuente: Elaboración propia.

Source: Own preparation.

Table 5. Analysis of body composition by Bioimpedance measurement according to
parameters in 9 obese patients at the end of the 6 month follow up.
Parameters
Body fat percentage (%)
Musculo-skeletal mass (kg)
Visceral fat level (%)

Final Results
- 4.2
- 6.5 kilograms
-5

Source: Own preparation.

DISCUSSION
This intervention evidenced, as a relevant result, the
decrease of cardiovascular risk from an intermediate
level to a low level, due to the decrease in weight, blood
pressure numbers, and blood lipid levels, with the
intervention of the Lifestyle Medicine program in obese
patients of a private institution in Colombia.
Upon performing the bibliographical search in diﬀerent
data bases, we found that no published articles exist
that study the cardiovascular risk in an obese
population through the application of the lifestyle
medicine program in Latin America. However, a
publication exists regarding the famous Diabetes
Prevention Program (DPP), which is a closer vision to the
Lifestyle Medicine approach applied in Latin American
institutions (13) . This was an uncontrolled intervention

study implemented in ve public clinics in northern
Mexico, where health personnel were trained in the
management of obesity.
There was a high number of participant dropouts in the
study after 12 months (60%), for this reason the study
was centered mainly on the results at 6 months. In a
similar way, this study was centered on the 6-month
follow-up of obese Colombian patients who
participated in a Lifestyle Medicine program, which
included group activities, individual consultations with
nutrition, psychology, and Lifestyle Medicine,
bioimpedance measurements with inbody 120
equipment, which had a follow-up through text
messages and phone calls.
The study performed in Mexico concluded that the
intensive lifestyle medicine program is eﬀective when
applied by personnel that usually provides medical care
Pág. 116
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to patients in real life, at least short-term. Furthermore,

The approach and intervention of these patients was

we accomplished the decrease of two factors that

performed in a multidisciplinary form where an internal

increased cardiovascular risk such as obesity and

medicine physician expert in nutrition, a licensed

arterial hypertension . IN our study we evidenced the

psychologist, and a licensed nutritionist participated, all

decrease of intermediate cardiovascular risk in our

with lifestyle medicine training. Keeping in mind the

patients from 22% to 0%, and patients with low risk at

presented statistics and what was evidenced during the

the beginning of the program were able to maintain the

psychological consultation we found that the greater

same level throughout the Colombian Lifestyle

drop-out was 88% of total participants, which was

(13)

Medicine program. The program applied in our study

evidenced during the fth month of follow-up. This

improved the blood pressure values of the study

could be because the treated patients did not show

subjects, revealing the normalization of arterial

interest for the treatment they were oﬀered, they had

pressure in 11% of participants.

not internalize the problem of their situation, leaving
aside the importance of mental health programs to

Some randomized controlled trials show that the

achieve treatment adherence, especially regarding

subjects in the study evidence weight loss of 5% to 10%

behavioral changes. This is supported by Orozco-

of their initial weight, up to 1 year after a high intensity

Gomez, who argues that “one of the intervention

lifestyle medicine intervention (14) . Weight reduction

techniques is the motivational interview, which enables

was also an important result of our study. From the

acquiring a commitment for behavioral change,

applied program, we were able to improve our patients

through acknowledgment and empowerment of

who presented type 3 obesity to type 2 obesity over the

present and potential problems”(19) , ==. Even when few

course of 6 months the intervention lasted. This

patients attended the psychological consultation, we

decrease could in uence the reduction in risk of

were able to decrease anxiety levels among the

developing diabetes up to 20%, however, this must be

participants from a high level to an intermediate level,

shown by carrying out posterior analytical studies (15) .

in their majority.

Furthermore, the bioimpedance measurement which is
a tool that proves the metabolic impact in obese

One of the study’s limitations was the sample size, not

patients allows us to measure the percentages of fat,

having the results of the other lipid pro le parameters

muscle, and visceral fat, demonstrating an important

(HDL, TG) and glucose, which is why, these variables

decrease in body fat, muscle mass, and visceral fat

were not taken into account in this study. Furthermore,

percentages (16) .

although we evidenced that patients were able to
decrease the stress levels by attending psychological

It is clearly evidenced that not only the decrease in

consultations, some of them did not attend these

weight is associated with a better control of diabetes

evaluations. We believe that multicentric research

and arterial hypertension, but also a diet low in

should be considered, not only for learning about the

carbohydrates

, which is why a

results of the Lifestyle Medicine Program application in

nutritional plan was provided, with a prescription of

other institutions but for generalizing the results

daily physical activity, in addition, the participants

obtained about the bene ts of the lifestyle medicine

(17)

, and plant-based

(18)

carried out a record of daily activities where the

application, and more so because this type of

following data was included: amount of food per day,

intervention has not been carried out in Colombian

mood, daily hours of sleep, amount of daily minutes to

territory. Furthermore, the obtained results should be

perform physical activity, level of satiety with food. With

used to nd the control or reversion of diﬀerent chronic

the support of this program, we aim to reduce the need

diseases, some of which are hypertension or type 2

for pharmacological treatment for chronic diseases

diabetes mellitus, which is why we recommend

such as arterial hypertension and type 2 diabetes

performing longitudinal studies that imply follow-ups

mellitus.

greater than six months
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It is novel to apply a program with the mentioned

CONCLUSIONS

characteristics in this study, where we did not use
medication or drugs for weight loss, but only applied

Due to the results presented and discussed, we

protocols under scienti c evidence of Lifestyle

conclude that the implementation of a Lifestyle

Medicine. The decrease of costs for use of drugs was

Medicine program applied locally (Colombia) could

able to decrease the nancial burden of obese patients.
Posing this proposal would save health systems an
economic burden that with time would become
unsustainable, acknowledging that the economic
impact of attention to comorbidities associated with

reduce the magnitude of cardiovascular risk and
improve the metabolic control of people with chronic
diseases. According to this, institutional services
rendered with a focus on Lifestyle Medicine could

obesity in Colombia rises to 2,158 million dollars (20) . For

improve the burden of non-transmissible chronic

the aforementioned, it would be convenient to

disease such as obesity, aﬀecting in the decrease of

continue strengthening the application of Lifestyle

blood pressure levels. Finally, having a quali ed team in

Medicine in the primary care, promotion and

Lifestyle Medicine in the health institutions of

prevention and even secondary care programs, for the

Colombia, oﬀers the possibility of improving the health

integral bene t of participants.

of people that access the national health services.
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